Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up - PubMed (original) (raw)

Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

Salvatore Novo et al. Cardiovasc Diabetol. 2013.

Abstract

Background: Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events.

Patients: We studied a population of 529 asymptomatic patients (age 62 ± 12.8 years), divided into two groups of subjects with and without Metabolic Syndrome (MetS).

Methods: All patients, at baseline, have had a carotid ultrasound evaluation and classified in two subgroups: the first one without atherosclerotic lesions and the second one with preclinical atherosclerosis (increased IMT or asymptomatic carotid plaque). Cardiovascular endpoints were investigated in a 20-years follow-up.

Results: There were 242 cardiovascular events: 144 among patients with MetS and 98 among in healthy controls (57.4% vs. 35.2%; P < 0.0001). 63 events occurred in patients with normal carotid arteries, while 179 events occurred in patients with preclinical atherosclerosis (31.8% vs. 54.1%; P < 0.0001). Of the 144 total events occurred in patients with MetS, 36 happened in the subgroup with normal carotid arteries and 108 in the subgroup with preclinical atherosclerosis (45% vs. 63.15%; P = 0.009). 98 events occurred in patients without MetS, of which 27 in the subgroup with normal carotid arteries and 71 in the subgroup with preclinical atherosclerosis (22.88% vs. 44.37%; P = 0.0003). In addition, considering the 63 total events occurred in patients without atherosclerotic lesions, 36 events were recorded in the subgroup with MetS and 27 events in the subgroup without MetS (45% vs. 22.88%; P = 0.0019). Finally, in 179 total events recorded in patients with preclinical carotid atherosclerosis, 108 happened in the subgroup with MetS and 71 happened in the subgroup without MetS (63.15% vs. 44.37%; P = 0.0009). The Kaplan-Meier function showed an improved survival in patients without atherosclerotic lesions compared with patients with carotid ultrasound alterations (P = 0.01, HR: 0.7366, CI: 0.5479 to 0.9904).

Conclusions: Preclinical atherosclerosis leads to an increased risk of cardiovascular events, especially if it is associated with MetS.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Prevalence of the cardiovascular risk factors in the study population.

Figure 2

Figure 2

Comparison of incidence of events in the subgroups of study.

Figure 3

Figure 3

Distribution of cardiovascular events in relation to preclinical atherosclerosis and MetS.

Figure 4

Figure 4

Event-free survival according to the Kaplan Meyer function.

Similar articles

Cited by

References

    1. Dahl-Jørgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia. 2005;12:1445–1453. - PubMed
    1. Panayiotou AG, Griffin M, Kouis P, Tyllis T, Georgiou N, Bond D, Nicolaides AN. Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol Metab Syndr. 2013;12(1):44. - PMC - PubMed
    1. Koskinen J, Kahonen M, Viikari JSM. Conventional CV risk factors and MetS in predicting carotid intima-media thickness progression in young adults. The CV risk in young Finns study. Circulation. 2009;12:229–236. - PubMed
    1. Heiss G, Sharrett AR, Barnes R. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;12:250–256. - PubMed
    1. Lande MB, Carson NL, Roy J. Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension. 2006;12:40–44. - PubMed

MeSH terms

LinkOut - more resources